Gelonghui, May 9 | Kaisheng New Materials (301069.SZ) said on the investor interactive platform that the company has not yet directly entered the field of synthetic biology. The company firmly focuses on the “one chain, two wings” enterprise development strategy, continuously improves products based on the sulfoxide chloride industry chain, and vigorously expands products in the field of new materials and new energy downstream.
凯盛新材(301069.SZ)：目前暂未直接涉足合成生物领域
Kaisheng New Materials (301069.SZ): Currently not directly involved in the field of synthetic biology
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.